Improving ICU Capacity During COVID-19 Outbreaks

Improving ICU Capacity During COVID-19 Outbreaks

Harnessing AI to better manage ICU capacity during crisis.

Project Overview

The Problem

Access to intensive care is critical for public health.

Prior to the COVID-19 pandemic, Canadian intensive care units (ICUs) were already operating at about 90 per cent capacity and exceeded capacity for about 50 days a year. ICU overcrowding causes delays in critical care for patients that need it most – every hour that ICU admission is delayed for a patient result in a 1.5 per cent increase in risk of death.

Respiratory infections such as pneumonia and influenza account for 20 per cent of ICU admissions and were a leading cause of death worldwide prior to COVID-19. With COVID-19 driving an increased demand for the ventilators, specialized treatments and close monitoring by doctors in ICUs, the entire health system is at greater threat of being overwhelmed.

How We Are Solving It

The Improving ICU Capacity During COVID-19 Outbreaks project aims to change that by developing software that can predict COVID-19 in-patient outcomes based on radiological imaging. The software will predict if and when a patient will likely need to be admitted to the ICU as well as their expected date of discharge. This information will help clinicians better plan for ICU bed capacity, staffing and ventilator availability.

Led by Altis Labs in partnership with Bayer AG, University Health Network, Trillium Health Partners and QIPCM, the project is helping ICUs manage capacity to ultimately deliver higher quality care, efficiency gains and better patient outcomes.

The project is applying prediction technology to standard-of-care medical images of in-patients with pulmonary infections to predict ICU admission and their expected date of discharge. In addition, the machine learning-based software takes into account pulmonary hypertension, cardiovascular disease and COPD, all of which can impact outcomes of COVID-19 patients. Published test results have shown that the software can improve prognosis accuracy by 68 per cent for lung cancer patients.

The project team will integrate the technology into a medical imaging platform deployed in hospitals, so that the software can be quickly implemented across health authorities.

The project will start rolling out in the Greater Toronto area before expanding across Canada.

Project Lead

  • Altis Labs Logo

Project Partners

  • Bayer Logo
  • Trillium Health Partners Logo
  • UHN Logo
  • QIPCM Logo

Get involved now!

We’re not waiting for the future. We’re creating it.

Become a Member

Are you ready to solve society's toughest challenges?